- Home
- CRVS vs CIA Comparison
CRVS vs CIA Comparison
Compare CRVS & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- CIA
- Stock Information
- Founded
- CRVS 2014
- CIA 1969
- Country
- CRVS United States
- CIA United States
- Employees
- CRVS N/A
- CIA N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- CIA Life Insurance
- Sector
- CRVS Health Care
- CIA Finance
- Exchange
- CRVS Nasdaq
- CIA Nasdaq
- Market Cap
- CRVS 206.5M
- CIA 212.6M
- IPO Year
- CRVS 2016
- CIA N/A
- Fundamental
- Price
- CRVS $3.61
- CIA $4.04
- Analyst Decision
- CRVS Strong Buy
- CIA
- Analyst Count
- CRVS 3
- CIA 0
- Target Price
- CRVS $16.33
- CIA N/A
- AVG Volume (30 Days)
- CRVS 1.6M
- CIA 82.4K
- Earning Date
- CRVS 05-08-2025
- CIA 05-27-2025
- Dividend Yield
- CRVS N/A
- CIA N/A
- EPS Growth
- CRVS N/A
- CIA N/A
- EPS
- CRVS N/A
- CIA 0.17
- Revenue
- CRVS N/A
- CIA $242,941,000.00
- Revenue This Year
- CRVS N/A
- CIA $5.58
- Revenue Next Year
- CRVS N/A
- CIA $5.06
- P/E Ratio
- CRVS N/A
- CIA $24.95
- Revenue Growth
- CRVS N/A
- CIA 0.19
- 52 Week Low
- CRVS $1.75
- CIA $2.05
- 52 Week High
- CRVS $10.00
- CIA $5.95
- Technical
- Relative Strength Index (RSI)
- CRVS 50.22
- CIA 46.18
- Support Level
- CRVS $3.46
- CIA $3.62
- Resistance Level
- CRVS $4.53
- CIA $4.32
- Average True Range (ATR)
- CRVS 0.28
- CIA 0.24
- MACD
- CRVS 0.02
- CIA 0.02
- Stochastic Oscillator
- CRVS 32.60
- CIA 48.26
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.